united kingdomen
Quant chart: enhancing emerging market factors

Quant chart: enhancing emerging market factors

16-08-2022 | Insight
Emerging markets have proven to be fruitful for well-established equity factors. Moreover, our research shows that these generic equity factors can be substantially enhanced for emerging markets.
  • Matthias Hanauer
    Matthias
    Hanauer
    Researcher
  • Weili  Zhou
    Weili
    Zhou
    Head of Quant Equity Research

Emerging markets account for around 58% of global GDP and this is forecasted to rise to 61% by 2026.1 Furthermore, more than 70% of the world’s population lives in these countries. However, emerging markets only represent about 12% of the MSCI All Country Index.

That said, the outlook for emerging markets has improved. As a group, emerging market stocks are cheaper than their developed market peers, partly due to the former lagging the latter in terms of performance over the last ten years. Thus on valuation grounds, they present an attractive prospect for global investors. Furthermore, our research shows there is a strategic case for allocating to emerging markets on an overall portfolio level.2

The macroeconomic backdrop could also provide support for emerging markets, given the group has a substantial current account surplus and is less troubled by inflation. Moreover, some individual countries even have room for fiscal and monetary stimulus.3 And while sustainable investing in emerging markets is considered challenging, our recent study illustrates that sustainable emerging market companies are actually as ‘green’ as those in developed markets.4

Stay informed on Quant investing with monthly mail updates
Stay informed on Quant investing with monthly mail updates
Subscribe

Emerging markets are fertile ground for quant factors

Historically, well-established factors have delivered solid performance in emerging markets. This is depicted in Figure 1 which highlights the annualized Sharpe ratios of both generic and enhanced value, quality, momentum and multi-factor (25% value, 25% quality, and 50% momentum) portfolios.

While generic value (book to market), quality (return on equity) and momentum (price momentum) factors exhibit positive Sharpe ratios ranging roughly between 0.1 and 0.6, their multi-factor combination achieves a Sharpe ratio of 0.8 due to diversification benefits.

Source: Refinitiv, Robeco. The figure shows the annualized Sharpe ratio of generic versus enhanced value, quality, momentum and multi-factor (25% value, 25% quality, and 50% momentum) composite factors. Factor returns are the return spreads between the top and bottom factor quintile portfolios. Portfolios are equal-weighted, rebalanced monthly and the holding period is six months. The investment universe consists of the non-financial constituents of the MSCI Emerging Markets Index. Before 2001, we use the largest 800 constituents of the S&P Emerging BMI at the semi-annual index rebalance going back to December 1995. The sample period is January 1996 to July 2022.

Enhanced factors have superior risk-adjusted performance

Our research demonstrates that these generic definitions can be substantially enhanced.5 For instance, the enhanced value composite6 that considers a broader range of fundamentals, such as earnings, cashflows, payouts, and intangible-adjusted book value, boosts the Sharpe ratio to nearly 0.8.

Similarly, a composite of quality metrics that has been shown to predict future growth in profitability (gross profitability, accruals, and investments)7 nearly doubles the Sharpe ratio compared to backward-looking return on equity.

While generic price momentum offers an attractive Sharpe ratio of almost 0.6, price momentum returns are also highly negatively skewed, exposing them to large drawdowns from time to time. Our research shows that a momentum composite that also considers residual8 and earnings momentum (price momentum, residual price momentum and analysts’ earnings revisions) exhibits a higher premium and significantly moderates these momentum crashes.

Finally, the enhancements of the individual factors also translate to the multi-factor level (again 25% value, 25% quality, and 50% momentum) as the Sharpe ratio for the multi-factor combination increases from 0.8 to about 1.4.

1IMF, April 2022, “World economic outlook database”, IMF.
2De Groot, W., and Zhou, W., October 2018, “Strategic allocation to emerging markets factor premiums”, Robeco white paper.
3Van Rijn, A., June 2022, “Anyone for hiking this summer?”, Robeco article.
4De Groot, W., and Sulman, V., June 2022, “Marrying sustainability and emerging markets expertise in quantitative strategies”, Robeco article.
5Robeco has published numerous papers on emerging markets over the last two decades. See for example: van der Hart, J., Slagter, E., and van Dijk, D., 2003, “Stock selection strategies in emerging markets”, Journal of Empirical Finance; van der Hart, J., de Zwart, G., and van Dijk, D., 2005, “The success of stock selection strategies in emerging markets: Is it risk or behavioral bias?”, Emerging Markets Review; Blitz, D., Pang, J., and van Vliet, P., 2013, “The volatility effect in emerging markets”, Emerging Markets Review; Hanauer, M. X., and Lauterbach, J. G., 2019, “The cross-section of emerging market stock returns”, Emerging Markets Review.
6Blitz, D., and Hanauer, M. X., January 2021, “Resurrecting the value premium”, Journal of Portfolio Management.
7Kyosev, G., Hanauer, M. X., Huij, J., and Lansdorp, S., May 2020, “Does earnings growth drive the quality premium”, Journal of Banking and Finance.
8Lansdorp, S., October 2013, “Robeco’s residual momentum: less risky and more sustainable”, Robeco article.

Logo

Disclaimer

Please read this important information before proceeding further. It contains legal and regulatory notices relevant to the information contained on this website.

The information contained in the Website is NOT FOR RETAIL CLIENTS - The information contained in the Website is solely intended for professional investors, defined as investors which (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive (MiFID), (2) have requested to be treated as professional clients within the meaning of the MiFID or (3) are authorized to receive such information under any other applicable laws. The value of the investments may fluctuate. Past performance is no guarantee of future results. Investors may not get back the amount originally invested. Neither Robeco Institutional Asset Management B.V. nor any of its affiliates guarantees the performance or the future returns of any investments. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency.

In the UK, Robeco Institutional Asset Management B.V. (“ROBECO”) only markets its funds to institutional clients and professional investors. Private investors seeking information about ROBECO should visit our corporate website www.robeco.com or contact their financial adviser. ROBECO will not be liable for any damages or losses suffered by private investors accessing these areas.

In the UK, ROBECO Funds has marketing approval for the funds listed on this website, all of which are UCITS funds. ROBECO is authorized by the AFM and subject to limited regulation by the Financial Conduct Authority. Details about the extent of our regulation by the Financial Conduct Authority are available from us on request.

Many of the protections provided by the United Kingdom regulatory framework may not apply to investments in ROBECO Funds, including access to the Financial Services Compensation Scheme and the Financial Ombudsman Service. No representation, warranty or undertaking is given as to the accuracy or completeness of the information on this website.

If you are not an institutional client or professional investor you should therefore not proceed. By proceeding please note that we will be treating you as a professional client for regulatory purposes and you agree to be bound by our terms and conditions.

If you do not accept these terms and conditions, as well as the terms of use of the website, please do not continue to use or access any pages on this website.

I Disagree